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Scientific and policy interests in the health
effects of particulate air pollution have
increased dramatically in the past decade in
response to numerous epidemiologic reports of
increased daily mortality associated with
episodes of particulate air pollution (1,2). In a
recent comprehensive analysis of daily mortal-
ity and particulate air pollution in 90 U.S.
cities, Samet and colleagues (3–5) conﬁrmed
that these associations were real, robust, and
not confounded by weather; furthermore,
these particle effects were independent of the
effects of other co-pollutants. Analyses by
cause of death generally find larger relative
risks for respiratory deaths. For example, in a
combined analysis across six eastern U.S. cities,
each 10-µg/m3 increase in fine particle mass
[particulate matter with an aerodynamic diame-
ter less than 2.5 µm (PM2.5)] was associated
with an increase in total mortality of 1.7%,
compared to an increase of 3.3% in chronic
obstructive pulmonary disease deaths and
4.0% in pneumonia deaths (6). Increased rela-
tive risks are also generally reported for cardio-
vascular deaths (1). In the combined six-city
analysis, PM2.5 was associated with a 2.1%
increase in ischemic heart disease deaths.
Respiratory deaths (chronic obstructive pul-
monary disease, pneumonia, influenza)
accounted for only 8.5% of all deaths in the
United States in 1997, while cardiovascular
deaths (heart, cerebrovascular, and arterial dis-
eases) accounted for 39.5% (7). Thus, while
the relative effects of particulate air pollution
are larger for respiratory than for cardiovascu-
lar deaths, the numbers of deaths attributable
to particulate air pollution are much larger for
cardiovascular than for respiratory causes.
Understanding the mechanisms by which
these particle exposures produce sudden car-
diac events is important not only scientiﬁcally
but also in risk assessment and in setting public
policy. Epidemiology cannot show causation,
but innovative study designs do provide
insights into possible causal pathways. 
Several years ago several colleagues and I
investigated possible mechanisms by which
particles deposited in the lungs might produce
an immediate, fatal cardiac event. We hypoth-
esized that particle exposures might interfere
with oxygen transport and that the resultant
hypoxemia might trigger cardiac arrhythmias.
To test this hypoxemia hypothesis, we
recruited two panels of elderly subjects living
in Utah Valley, Utah (18). One panel con-
sisted of emeritus faculty from Brigham Young
University and their spouses living in Orem
and Provo. The other panel consisted of resi-
dents in an assisted living facility in Orem.
Members of the ﬁrst panel measured their oxy-
gen saturation twice daily (on arising and
before retiring) with a pulse oximeter. Pulse
rate, oxygen saturation, date, and time were
automatically recorded. Residents of the retire-
ment community had the same measurements
made once a day—after the evening meal. 
This locale was chosen as the source of the
sample population for several reasons. First,
Utah Valley has frequent temperature inver-
sions during the winter, which lead to ele-
vated particulate air pollution episodes. Air
pollution [particulate matter with a mass
median aerodynamic diameter less than 10 µ
(PM10) and carbon monoxide] is routinely
measured at multiple sights in the Valley.
Second, the Valley is at a high elevation,
about 1,400 m above sea level (average baro-
metric pressure 656 mmHg). Thus, these
subjects have decreased oxygen tension
because of the decreased partial pressure of
oxygen. Because they are on the steep side of
the oxygen dissociation curve, these subjects
would be expected to show more variability
in their oxygen saturation than subjects at sea
level. Third, the rate of smoking, a major
source of reduced oxygen saturation due to
carboxyhemaglobin, is very low in this
community. Finally, increased cardiovascular
deaths associated with PM10 concentrations
had been convincingly demonstrated previ-
ously in the same community (9). 
Daily oxygen saturation measurements
were collected from 90 subjects for 3 months
during the winter of 1995 and 1996. We
found a strong positive correlation between
barometric pressure and daily mean oxygen
saturation of the subjects (8,10). This obser-
vation demonstrated that with the study
design used, even this crude measure of
hypoxemia could detect the expected physio-
logic link between partial pressure of oxygen
in the air and oxygen saturation of the blood.
Nevertheless, we found no association of oxy-
gen saturation of the blood with PM10 (or car-
bon monoxide) concentrations (9). Thus, this
study suggested that hypoxemia was not a fac-
tor in the mechanistic pathway between PM
air pollution exposures and cardiac deaths. 
In addition to oxygen saturation, the
pulse oximeter also recorded pulse rate. Not
wanting to waste good data (and not being
averse to analyzing data outside the primary
hypothesis), we analyzed the association of
pulse rate and PM10 concentrations. To our
surprise, we found a statistically significant
positive association between increased pulse
rate and PM10 (9). The magnitude of this
effect in terms of increased beats per minute
was physiologically small (0.8 beat per
minute increase for 100 µg/m3 increase in
PM10 on the previous day). However, we also
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found a significant increase in a clinically
relevant marker, i.e., the number of subjects
whose heart rate increased by more than 5
beats and also by 10 beats per minute
(increase of 29% and 95%, respectively, for
an increase of 100 µg/m3 in PM10 on the pre-
vious day). Thus, although we disproved our
original hypothesis of particulate-induced
hypoxemia, we had the suggestion of a poten-
tial autonomic link. In a long-term prospec-
tive study of myocardial risk factors in
Augsburg, Germany, Peters et al. (11)
reported increased heart rate in the partici-
pants who were examined during a major air
pollution episode.
Separately, studies of dogs exposed to
concentrated ambient air particles by our col-
leagues at the Harvard School of Public
Health (12) showed morphologic changes in
electrocardiograms (ECGs) during and after
exposure to concentrated ambient particles.
In collaboration with those investigators, we
designed a pilot study to assess whether simi-
lar electrocardiographic changes could be
observed in free-living humans. We borrowed
several Holter monitors; Pope and his col-
leagues in Utah convinced six of the partici-
pants in the oximetry study plus one of the
ﬁeld technicians to wear an ambulatory ECG
monitor for 24–48 hr on up to three occa-
sions (10). The plan was to measure ECGs on
each subject before, during, and after the
PM10 episodes. Luckily, soon after we began
the ECG monitoring, PM10 concentrations
rose to the highest levels of the winter (maxi-
mum 147 µg/m3 ). A change in air mass then
cleared the Utah Valley and very low levels of
PM10 continued for the rest of the winter.
Thus, electrocardiographic data were col-
lected over a wide range of PM10 exposures
for each subject.
We calculated the daily average pulse rate
and the standard deviation of the intervals
between normal beats (SDNN). As a measure
of heart rate variability, the SDNN is an indi-
cator of autonomic tone that is a gross mea-
sure of how well the heart can respond to
external stress. SDNN generally decreases
with age. It is also lower during illness. Low
SDNN is associated with poor cardiovascular
prognosis (13,14). Among the seven partici-
pants in the Utah Valley ECG study, there
were large differences in individual SDNN
(10). However, for each individual, SDNN
decreased with increasing PM10 concentra-
tions (Figure 1). Thus, this small pilot study
suggested that particulate air pollution was
associated with reduced heart rate variability
in these healthy, elderly subjects. We also
learned that these study subjects, although
highly motivated and committed to this
study, found the repeated 24-hr Holter moni-
toring of ECGs to be very burdensome, and
so an alternative data collection procedure
would be required if we were to collect simi-
lar data in the future. 
An alternative, more acceptable study
design was to measure ECG with an ambu-
latory monitor repeatedly for a short period
under controlled conditions. In a pilot
study of 21 subjects living in a Boston,
Massachusetts, residence for the elderly,
ECGs were measured once a week during the
summer of 1997 (15). ECGs were measured
during a defined 30-min assessment during
which the subjects engaged in 5-min periods
of lying down, sitting up, standing, walking
outside, sitting, and paced breathing.
Analysis of the data gathered showed that
ﬁne particle concentrations in the 4 hr before
ECG monitoring were associated with
decreased heart rate variability. Researchers
at the U.S. Environmental Protection
Agency also reported particulate air pollution
exposures were associated with decreased
heart rate variability in panels of elderly
subjects in Baltimore, Maryland (16). 
These panel studies provide repeated
snapshots of cardiac function at a specific
time during the day. There is interest, how-
ever, in continuous ECG monitoring of vul-
nerable subjects, since most tachyarrhythmias
occur at night or during the early morning.
Cardiac patients with evidence of arrhythmias
often have implanted devices that continu-
ously measure their ECGs. For example, a
growing number of cardiac patients have
received implanted cardioverter deﬁbrillators
(ICDs). The ICD is implanted under the
skin on the shoulder; an electrode is passed
from the deﬁbrillator through a vein into the
right side of the heart, and attached to the
ventricular wall. These devices actively moni-
tor cardiac rhythm for abnormalities. Upon
detection of a sustained ventricular tachycar-
dia or ventricular fibrillation, the ICD can
initiate a range of therapies, from pacing
shocks to cardioverter shocks, to restore
proper electrical function. 
Patients return for clinical follow-up every
3 to 4 months, or in some cases whenever
they are aware of a therapeutic discharge by
the device. The dates, times, and characteris-
tics of any detected arrhythmias and therapies
are recorded automatically by the ICD and
are downloaded in the clinic by radio links.
Thus, these patients are passively monitored
continuously for cardiac arrhythmias and the
dates and times of any events are recorded as
part of their routine clinical management. 
We evaluated the utility of the data from
the ICD as an indicator of acute cardiovascu-
lar response to air pollution in a pilot study in
Boston (17). The dates and times of ICD dis-
charge events were abstracted for a panel of
100 patients who live in the Boston area who
were followed at the Beth Israel Deaconess
Medical Center Device Clinic. The probabil-
ity of a therapeutic intervention on any given
day was compared to the daily measures of air
pollution. We observed that an 18-µg/m3
increase in 5-day mean PM2.5 was associated
with a 22% increase in the probability of an
Figure 1. Twenty-four hour mean SDNN versus PM10
pollution levels (µg/m3) and individual regression lines
for seven individuals followed in Utah Valley. Symbols
indicate different individuals (n = 7). Data from Pope et
al. (8).
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Figure 2. Odds ratio and 95% conﬁdence interval for implanted cardioverter deﬁbrillator discharge versus quantities
of PM2.5 exposure estimated for previous 2 hr and days simultaneously. MI, mycocardial infarction; OR, odds ratio.
Data from Peters et al. (17).
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ICD discharge. Stronger associations were
found with black carbon particle mass and
nitrogen dioxide exposures, all indicators of
automobile and truck emissions. Thus, we
had evidence that suggested that air pollution
episodes could stimulate acute cardiovascular
arrhythmias, which if not detected or cor-
rected by the implanted cardioverter deﬁbril-
lators, might have resulted in sudden death. 
These observations led to analyses of the
role of air pollution in the onset of myocar-
dial infarctions, using data from an existing
study. In that study, survivors of confirmed
myocardial infarctions were interviewed in
the hospital as soon as possible after admis-
sion to determine the time of onset of symp-
toms and their activities immediately before
the onset (18). The risk of specific activities
was estimated using a case-crossover analysis
in which activities immediately before the
onset of symptoms were compared to activi-
ties in matched periods. This study docu-
mented, for example, the increased risk of
exercise (19), stress (20), anger (18), and
cocaine use (21) on the onset of myocardial
infarctions. We applied the same strategy to
assess the risk of acute air pollution exposures
for periods immediately before onset of
myocardial infarctions with matched control
periods (22). Data were available for 833
patients with confirmed myocardial infarc-
tion in the greater Boston area for 1995 and
1996. Hourly PM2.5 concentrations were
available for the same period from a single
monitoring site in Boston. We found an
increased risk of myocardial infarction for the
1–2 hr following an elevated PM2.5 exposure
and separately for the 1–2 days after an
elevated 24-hour mean PM2.5 exposure.
Although PM2.5 concentrations for these two
time scales are clearly correlated, we found
that these effects are separable and additive
(Figure 2). This suggestion of immediate (2
hr) and delayed (2 days) response suggest that
particles affect cardiovascular function by
more than one mechanism. 
The studies have provided further
evidence that particulate air pollution expo-
sures are associated with acute cardiovascular
events. However, the studies do not identify
the mechanism for these associations. Seaton
et al. (25) suggested that particulate air pollu-
tion might act through pulmonary inﬂamma-
tion to trigger systemic hypercoagulability of
the blood. Stone and Godleski (24) recently
suggested that particle exposures might inﬂu-
ence the sympathetic/parasympathetic bal-
ance, possibly through local inﬂammation in
the lung or systemic inflammation. Is there
evidence of systematic inflammation associ-
ated with particulate air pollution exposures? 
Analysis of blood parameters measured in
the MONICA study in Augsburg, Germany,
has provided several interesting suggestions
on the role of air pollution. The MONICA
study was a large multinational prospective
assessment of the effects of myocardial risks
on survival. Subjects were assessed for cardio-
vascular function in 1984 and 1985 and
again in 1987 and 1988. By chance a major
air pollution episode affected the Augsburg
study site in January 1985 during the first
survey. Blood collected during this period has
been compared to blood collected during
other sample days in the 1984/1985 survey
and to follow-up periods for the same indi-
viduals. Peters and colleagues (25) initially
reported higher plasma viscosity of blood
samples during the Augsburg air pollution
episode. Recently, they reported higher aver-
age levels of C-reactive protein (CRP) during
the air pollution episode (26), and that the
odds of having a high CRP level (> 90th per-
centile) increased with total suspended parti-
cle levels (Figure 3). Recent studies have
shown that elevated CRP concentrations, a
marker of cell damage and inﬂammation, are
associated with substantially increased risk of
sudden cardiac death (27). These results sug-
gest a new line of investigation in which
serum markers would serve as early markers
to response to particulate air pollution. 
The earliest studies of particulate air
pollution and daily mortality (28–30) sug-
gested increased associations not only with res-
piratory deaths, but also with cardiovascular
deaths. The weakness in using death certiﬁcate
information to determine cause of death is well
known. Therefore, the initial explanation was
that these associations represented misclassiﬁ-
cation of respiratory disease as acute cardiovas-
cular events. It is still likely that chronic (or
acute) respiratory disease contributes to acute
cardiovascular deaths. However, recent epi-
demiologic studies show that particulate air
pollution exposures have a direct effect on
autonomic function of the heart, as seen by
changes in heart rate, heart rate variability, and
cardiac arrhythmias (Table 1). Epidemiologic
associations have been found not only with
cardiovascular deaths identified from death
certiﬁcates but also with clinically conﬁrmed
myocardial infarctions and ventricular ﬁbrilla-
tion that required cardioverter interventions.
New epidemiologic studies suggest associations
with early serum markers of risk for sudden
death, including coagulability and inﬂamma-
tion. The strong indications of increased risk
for sudden cardiac events associated with par-
ticulate air pollution noted in the epidemio-
logic studies might have been expected based
on recent observations from controlled animal
exposures. On the other hand, the epidemio-
logic findings raise important questions that
only can be fully addressed in toxicologic and
physiologic studies. 
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